WallStreetZenWallStreetZen

NASDAQ: HALO
Halozyme Therapeutics Inc Stock Ownership - Who owns Halozyme Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Halozyme Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nicole LabrosseSVP CHIEF FINANCIAL OFFICER2025-09-106,760$75.29
$508.97kSell
Nicole LabrosseSVP CHIEF FINANCIAL OFFICER2025-09-101,135$12.49
$14.18kBuy
Nicole LabrosseSVP CHIEF FINANCIAL OFFICER2025-09-1011,271$12.07
$136.04kBuy
Nicole LabrosseSVP CHIEF FINANCIAL OFFICER2025-09-1013,240$75.93
$1.01MSell
Helen TorleyPRESIDENT AND CEO2025-09-047,800$74.33
$579.75kSell
Helen TorleyPRESIDENT AND CEO2025-09-049,900$73.54
$728.01kSell
Helen TorleyPRESIDENT AND CEO2025-09-0420,000$8.11
$162.20kBuy
Helen TorleyPRESIDENT AND CEO2025-09-042,300$75.22
$173.02kSell
Helen TorleyPRESIDENT AND CEO2025-09-039,500$74.22
$705.09kSell
Helen TorleyPRESIDENT AND CEO2025-09-0320,000$8.11
$162.20kBuy

1 of 10

HALO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HALO insiders and whales buy or sell their stock.

HALO Shareholders

What type of owners hold Halozyme Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk22.77%26,633,924$2.02BInsider
Blackrock Inc11.29%13,200,032$1.00BInstitution
Vanguard Group Inc10.47%12,245,602$928.83MInstitution
State Street Corp5.07%5,935,045$450.17MInstitution
Gregory Ian Frost3.11%3,641,380$276.20MInsider
Invesco Ltd2.96%3,465,889$262.89MInstitution
Snyder Capital Management L P2.90%3,397,697$257.72MInstitution
Arrowstreet Capital Limited Partnership2.17%2,541,181$192.75MInstitution
Alliancebernstein LP2.10%2,455,268$186.23MInstitution
Geode Capital Management LLC2.08%2,432,509$184.51MInstitution

1 of 3

HALO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HALO77.22%22.78%Net SellingNet Selling
VRNA11.02%51.50%Net SellingNet Selling
MDGL26.16%73.84%Net BuyingNet Buying
RVMD90.56%9.44%Net BuyingNet Buying
TECH97.62%2.38%Net BuyingNet Buying
View Top Biotech Stocks

Halozyme Therapeutics Stock Ownership FAQ

Who owns Halozyme Therapeutics?

Halozyme Therapeutics (NASDAQ: HALO) is owned by 100.31% institutional shareholders, 29.60% Halozyme Therapeutics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Halozyme Therapeutics shareholder, owning 26.63M shares representing 22.77% of the company. Randal J. Kirk's Halozyme Therapeutics shares are currently valued at $2.02B.

If you're new to stock investing, here's how to buy Halozyme Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.